Fyodorov–Zuev keratoprosthesis implantation: long-term results in patients with multiple failed corneal grafts
- 175 Downloads
- 9 Citations
Abstract
Background
The long term results of the Fyodorov–Zuev keratoprosthesis are presented for ten patients with repeated graft failures.
Methods
The study took place at Dr Khodadoust Eye Hospital. The Fyodorov–Zuev keratoprosthesis was implanted in ten patients with repeated graft failures, including seven patients with old trachoma, two patients with chemical injury, and a patient with thermal injury. The outcome measures were visual acuity, retention, and complications of the keratoprosthesis.
Results
Preoperative best-uncorrected visual acuity (BUVA) ranged from counting fingers to light perception (median: light perception). The keratoprosthesis dramatically improved vision in most patients. Patients retained BUVA of 20/200–20/50 in 50%, 20/60–20/100 in 30%, 20/200 in 10% and 20/400 in 10%. Overall, 90% had 1 year postoperative vision of 20/200 or better. 70% of cases had BUVA of 20/200 or better at the last follow-up (average 52 months). Of ten keratoprosthesis implanted, three have been removed, and as a result, retention rate was 70% during average follow-up of 52 months .The most common postoperative complications were retroprosthetic membrane formation (40%), uveitis (20%), glaucoma (20%), tissue overgrowth (20%), early leakage (20%), late leakage (20%), aseptic necrosis (20%), retinal detachment (10%), endophthalmitis (10%), and granulation tissue growth (10%).
Conclusions
Fyodorov–Zuev keratoprosthesis is an effective means of managing repeated corneal graft failure.
Keywords
Fyodorov–Zuev keratoprosthesis Repeated graft failures Visual recovery ComplicationsNotes
Acknowledgements
The authors are grateful to Prof. Leonid Legkikkh, Prof. Kalinnikov from Svyatoslav N. Fyodorov Eye Microsurgery Research and Technology Complex, Moscow , Prof. Kasparov from Krasnove eye Institute, Moscow, Prof. Konrad Hille from Augenklinik, Klinikum Offenburg, Germany , Prof. Christopher Liu from Sussex Eye Hospital, Brighton, UK , Prof. Claes Dohlman and Prof. Mahnaz Nouri from Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, and Dr Sadollah Puyan from Dr Khodadoust Eye Hospital for their kind cooperation, and we also gratefully acknowledge the Dr Khodadoust Eye Hospital, Shiraz, Iran.
The authors got the Fyodorov–Zuev keratoprosthesis from the S. Fyodorov Eye Microsurgery Complex, Building 59-A, 127486, Beskudnikovskij Blvd, Moscow, Russia. Order Keratoprosthesis #15-09 by calling (495) 485 77 95, sending a request by fax (495) 485 77 95, (495) 905 81 47 or e-mail etp-mntk@mail.ru www.mntk.ru
References
- 1.Whitcher JP, Srinivasan M, Upadhyay M (2001) Corneal blindness: a global perspective. Bull World Health Organ 79(3):214–221PubMedGoogle Scholar
- 2.Muraine M, Sanchez C, Watt L, Retout A, Brasseur G (2003) Long-term results of penetrating keratoplasty: a 10-year-plus retrospective study. Graefes Arch Clin Exp Ophthalmol 241:571–576CrossRefPubMedGoogle Scholar
- 3.Liu C, Hille K, Tan D, Hicks C, Herold J (2008) Keratoprosthesis surgery. Dev Ophthalmol 41:171–186CrossRefPubMedGoogle Scholar
- 4.Dohlman CH, Dudenhoefer EJ, Khan BF, Morneault S (2002) Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J 28:72–74PubMedGoogle Scholar
- 5.Dohlman CH, Nouri M (2005) Keratoprosthesis surgery. In: Foster CS, Azar DT, Dohlman CH (eds) Smolin and Thoft’s the cornea, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1085–1095Google Scholar
- 6.Hull CC, Liu CS, Sciscio A, Eleftheriadis H, Herold J (2000) Optical cylinder designs to increase the field of vision in the osteo-odonto-keratoprosthesis. Graefes Arch Clin Exp Ophthalmol 238(12):1002–1008CrossRefPubMedGoogle Scholar
- 7.Fyodorov SN, Kivaev AA, Bagrov SN (1970) Keratoprosthesis in the case of serious leukomas and the endothelial epithelial dystrophy of the cornea clinical and experimental researches. Oftalmologicheskil Zhurnal 4:253–255Google Scholar
- 8.Moroz ZI, Kalinnikov IuIu, Kovshun EV, Borzenok SA, Komakh IuA (2007) Achievements of SN. Fyodorov's school in the field of keratoplasty and cornea replacement. Vestn Ross Akad Med Nauk 8:16–20PubMedGoogle Scholar
- 9.Ament JD, Stryjewski TP, Ciolino JB, Todani A, Chodosh J, Dohlman CH (2010) Cost-effectiveness of the Boston keratoprosthesis. Am J Ophthalmol 149(2):221–228CrossRefPubMedGoogle Scholar
- 10.Huang YF, Wang LQ, Wang FX (2003) Clinical application of keratoprosthesis for corneal opacity unsuitable for keratoplasty. Zhonghua Yan Ke Za Zhi 39:578–581PubMedGoogle Scholar
- 11.Alió JL, Mulet ME, Haroun H, Merayo J, Ruiz Moreno JM (2004) Five year follow up of biocolonisable microporous fluorocarbon haptic (BIOKOP) keratoprosthesis implantation in patients with high risk of corneal graft failure. Br J Ophthalmol 88:1585–1589CrossRefPubMedGoogle Scholar
- 12.Zerbe BL, Belin MW, Ciolino JB, Boston Type 1 Keratoprosthesis Study Group (2006) Results from the Multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 113:1779–1784CrossRefPubMedGoogle Scholar
- 13.Aldave AJ, Kamal KM, Vo RC, Yu F (2009) The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology 116(4):640–651CrossRefPubMedGoogle Scholar
- 14.Bersudsky V, Blum-Hareuveni T, Rehany U, Rumelt S (2001) The profile of repeated corneal transplantation. Ophthalmology 108:461–469CrossRefPubMedGoogle Scholar
- 15.Hille K, Landau H, Ruprecht KW (1999) Improvement of the osteo-odonto-keratoprosthesis according to Strampelli: influence of diameter of PMMA cylinder on visual field. Graefes Arch Clin Exp Ophthalmol 237(4):308–312CrossRefPubMedGoogle Scholar
- 16.Ma JJ, Graney JM, Dohlman CH (2005) Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure. Int Ophthalmol Clin 45(4):49–59CrossRefPubMedGoogle Scholar
- 17.Aquavella JV, Qian Y, McCormick GJ, Palakuru JR (2005) Keratoprosthesis: the Dohlman–Doane device. Am J Ophthalmol 140:1032–1038CrossRefPubMedGoogle Scholar
- 18.Hicks C, Hamilton S (2005) Retroprosthetic membranes in AlphaCor patients: risk factors and prevention. Cornea 24:692–698CrossRefPubMedGoogle Scholar
- 19.Yaghouti F, Nouri M, Abda JC, Power WJ, Doane MG, Dohlman CH (2001) Keratoprosthesis: preoperative prognostic categories. Cornea 20:19–23CrossRefPubMedGoogle Scholar
- 20.Aquavella JV, Rao GN, Brown AC, Harris JK (1982) Keratoprosthesis: results, complications and management. Ophthalmology 89:655–660PubMedGoogle Scholar
- 21.Netland PA, Terada H, Dohlman CH (1998) Glaucoma associated with keratoprosthesis. Ophthalmology 105:751–757CrossRefPubMedGoogle Scholar
- 22.Sayegh RR, Ang LP, Foster CS, Dohlman CH (2008) The Boston Keratoprosthesis in Stevens–Johnson syndrome. Am J Ophthalmol 145:438–444CrossRefPubMedGoogle Scholar
- 23.Khan RS, Dohlmann CH, D’Amico DJ (2002) Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol 120:559–566PubMedGoogle Scholar
- 24.Nouri M, Durand ML, Dohlman CH (2005) Sudden reversible vitreitis after keratoprosthesis: an immune phenomenon? Cornea 24:915–919CrossRefPubMedGoogle Scholar
- 25.Georgalas I, Kanelopoulos AJ, Petrou P, Ladas I, Gotzaridis E (2010) Presumed endophthalmitis following Boston keratoprosthesis treated with 25 gauge vitrectomy: a report of three cases. Graefes Arch Clin Exp Ophthalmol 248(3):447–450CrossRefPubMedGoogle Scholar
- 26.Nouri M, Terada H, Alfonso EC, Foster CS, Durand ML, Dohlman CH (2001) Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol 119:484–489PubMedGoogle Scholar